Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene.

IF 3.5 2区 医学 Q2 GENETICS & HEREDITY
Jana Horackova, Renata Taslerova, Milan Bayer, Jana Nekvindova, Ladislava Pavlikova, Jan M Horacek, Vladimir Palicka
{"title":"Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene.","authors":"Jana Horackova, Renata Taslerova, Milan Bayer, Jana Nekvindova, Ladislava Pavlikova, Jan M Horacek, Vladimir Palicka","doi":"10.1186/s13023-025-03804-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Juvenile Paget disease (JPD) is a rare autosomal recessive bone disease characterized by escalated bone metabolism leading to skeletal deformities, susceptibility to fractures, and some extraskeletal findings. This genetic disease is associated with changes in the TNFRSF11B gene encoding osteoprotegerin, an important regulator of osteoresorption. Most published JPD cases have been found to carry homozygous TNFRSF11B variants, while compound heterozygous variants in this gene have been reported only twice.</p><p><strong>Methods and results: </strong>We report the first case of JPD diagnosed in the Czech Republic, who presented with a mild phenotype of this disease. The first bone fractures, appeared at 3 years of age. Other clinical manifestations included typical skeletal deformities, macrocephaly, arched chest, lower extremity valgosity, lateral bowing of the thighs, and anterior bowing of the shins. Minor mixed hearing impairment, angioid stripes of the choroidea, and temporary immunodeficiency were present among extra-skeletal findings. Sanger sequencing was performed on both the patient and the parents to test for the presence of TNFRSF11B sequence variants. Molecular genetic analysis showed unique compound heterozygous sequence variants in TNFRSF11B: a paternally inherited variant c.30 + 5G > A, p.(?) and a maternally inherited variant c.329G > T, p.(Gly110Val). Both of the variants were analyzed by several in silico predictive tools indicating, for their strongly supported pathogenicity according to American College of Medical Genetics and Genomics standards. Furthermore, we present diagnostic findings, their treatment, and follow-up care.</p><p><strong>Conclusion: </strong>The newly described variants of TNFRSF11B extend knowledge of this very rare disease. Early diagnosis and antiresorption treatment prevent further fractures and deformity progression, and improve the patient's quality of life. This example of osteoprotegerin deficiency may help us better understand its role in skeletal and non-skeletal systems.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":"20 1","pages":"409"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333066/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orphanet Journal of Rare Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13023-025-03804-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Juvenile Paget disease (JPD) is a rare autosomal recessive bone disease characterized by escalated bone metabolism leading to skeletal deformities, susceptibility to fractures, and some extraskeletal findings. This genetic disease is associated with changes in the TNFRSF11B gene encoding osteoprotegerin, an important regulator of osteoresorption. Most published JPD cases have been found to carry homozygous TNFRSF11B variants, while compound heterozygous variants in this gene have been reported only twice.

Methods and results: We report the first case of JPD diagnosed in the Czech Republic, who presented with a mild phenotype of this disease. The first bone fractures, appeared at 3 years of age. Other clinical manifestations included typical skeletal deformities, macrocephaly, arched chest, lower extremity valgosity, lateral bowing of the thighs, and anterior bowing of the shins. Minor mixed hearing impairment, angioid stripes of the choroidea, and temporary immunodeficiency were present among extra-skeletal findings. Sanger sequencing was performed on both the patient and the parents to test for the presence of TNFRSF11B sequence variants. Molecular genetic analysis showed unique compound heterozygous sequence variants in TNFRSF11B: a paternally inherited variant c.30 + 5G > A, p.(?) and a maternally inherited variant c.329G > T, p.(Gly110Val). Both of the variants were analyzed by several in silico predictive tools indicating, for their strongly supported pathogenicity according to American College of Medical Genetics and Genomics standards. Furthermore, we present diagnostic findings, their treatment, and follow-up care.

Conclusion: The newly described variants of TNFRSF11B extend knowledge of this very rare disease. Early diagnosis and antiresorption treatment prevent further fractures and deformity progression, and improve the patient's quality of life. This example of osteoprotegerin deficiency may help us better understand its role in skeletal and non-skeletal systems.

Abstract Image

Abstract Image

Abstract Image

青少年Paget病与TNFRSF11B基因独特的复合杂合序列变异。
背景:少年Paget病(JPD)是一种罕见的常染色体隐性骨病,其特征是骨代谢升级导致骨骼畸形、骨折易感性和一些骨骼外表现。这种遗传疾病与编码骨保护素的TNFRSF11B基因的变化有关,骨保护素是骨吸收的重要调节因子。大多数已发表的JPD病例被发现携带纯合子TNFRSF11B变异,而该基因的复合杂合子变异仅报道过两次。方法和结果:我们报告的第一例JPD诊断在捷克共和国,谁提出了这种疾病的轻度表型。第一次骨折出现在3岁时。其他临床表现包括典型的骨骼畸形、大头畸形、胸部弓形、下肢外翻、大腿外侧弯曲和胫骨前屈。轻微的混合性听力障碍,脉络膜血管样条纹和暂时性免疫缺陷存在于骨骼外的发现。对患者和父母进行Sanger测序以检测TNFRSF11B序列变异的存在。分子遗传学分析显示,TNFRSF11B存在独特的复合杂合序列变异:父系遗传变异c.30 + 5G > a, p.(?)和母系遗传变异c.329G > T, p.(Gly110Val)。根据美国医学遗传学和基因组学学院的标准,对这两种变异进行了几种计算机预测工具的分析,表明它们强烈支持致病性。此外,我们提出诊断结果,他们的治疗和后续护理。结论:新发现的TNFRSF11B变异扩展了对这种非常罕见疾病的认识。早期诊断和抗吸收治疗可防止骨折和畸形进一步发展,提高患者的生活质量。这个骨保护素缺乏的例子可以帮助我们更好地理解它在骨骼和非骨骼系统中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases 医学-医学:研究与实验
CiteScore
6.30
自引率
8.10%
发文量
418
审稿时长
4-8 weeks
期刊介绍: Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信